Kilian W. Frieboes-Conde

Novo Nordisk A/S, Novo Nordisk Park
Malov, 2760, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Journal: Cell metabolism

Published: March 25, 2026

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

Journal: Journal of medicinal chemistry

Published: December 11, 2025

Variant screening of PYY3-36 leads to potent long-acting PYY analogs with superior Y2 receptor selectivity.

Variant screening of PYY3-36 leads to potent long-acting PYY analogs with superior Y2 receptor selectivity.

Journal: Science translational medicine

Published: March 26, 2025

Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist.

Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist.

Journal: Science translational medicine

Published: December 04, 2024

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia.

Journal: Cell metabolism

Published: June 11, 2024

Demonstration of a Common DPhe7 to DNal(2')7 Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides.

Demonstration of a Common DPhe7 to DNal(2')7 Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides.

Journal: Journal of medicinal chemistry

Published: April 11, 2022

Rational Development of Stable PYY3-36 Peptide Y2 Receptor Agonists.

Rational Development of Stable PYY3-36 Peptide Y2 Receptor Agonists.

Journal: Pharmaceutical research

Published: March 15, 2021

In vitro prediction of in vivo pseudo-allergenic response via MRGPRX2.

In vitro prediction of in vivo pseudo-allergenic response via MRGPRX2.

Journal: Journal of immunotoxicology

Published: February 11, 2021

UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.

UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.

Journal: American journal of physiology. Endocrinology and metabolism

Published: November 20, 2019

Diselenide-selenoester ligation for chemical protein synthesis.

Diselenide-selenoester ligation for chemical protein synthesis.

Journal: Nature protocols

Published: January 17, 2019

Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP Secretion.

Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP Secretion.

Journal: Nutrients

Published: February 28, 2017

Analytic framework for peptidomics applied to large-scale neuropeptide identification.

Analytic framework for peptidomics applied to large-scale neuropeptide identification.

Journal: Nature communications

Published: October 03, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026